Nurotron Biotechnology Co., Ltd.
PrivateLast Round
Strategic
May 15, 2025
Est. Valuation
$378.8M
Total Funding Raised
$17M
Company Overview
Nurotron Biotechnology Co., Ltd. is a medical device company that designs, develops, and manufactures neurostimulation systems, including cochlear implants, auditory brainstem implants, and other neural electrical stimulation rehabilitation products.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nurotron Biotechnology Co., Ltd. Comparables
Compare Nurotron Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
Nurotron Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 15, 2025 | ||||
| Strategic | May 16, 2024 | ||||
| VC Round | Jun 1, 2023 | ||||
| VC Round | Feb 1, 2021 | ||||
| Strategic | Sep 29, 2020 | ||||
Early Funding | Aug 1, 2019 |
Nurotron Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Strategic |
| Zhejiang Sino Wisdom Investment Management | Series B Extension |
| Chenghe Capital Management | Private Equity, VC Round |
| 德同资本 | Series C |
| Yinrun Capital | Early Funding |
| Tianyi Group | Series B Extension |
| Zhejiang Jiuren Capital Management Co., Ltd. | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 62% QoQ from 13 to 21 employees.
- Jun 1, 2023
Completed a VC Round fundraise.
Nurotron Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nurotron Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Nurotron Biotechnology Co., Ltd. a public or private company?
Nurotron Biotechnology Co., Ltd. is a private company.
What is the current stock price of Nurotron Biotechnology Co., Ltd.?
Nurotron Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Nurotron Biotechnology Co., Ltd. worth (valuation)?
Nurotron Biotechnology Co., Ltd.'s valuation is estimated at $367.1M based on funding round data.
Can I buy Nurotron Biotechnology Co., Ltd. stock?
Nurotron Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nurotron Biotechnology Co., Ltd.'s last funding round?
Nurotron Biotechnology Co., Ltd.'s most recent funding round was Strategic on September 29, 2020.
Who are the main investors in Nurotron Biotechnology Co., Ltd.?
Key investors in Nurotron Biotechnology Co., Ltd. include Qiming Venture Partners.
Will Nurotron Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Nurotron Biotechnology Co., Ltd..
How can I track Nurotron Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nurotron Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.